Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus and Entecavir in HBV-Associated Glomerulonephritis
NCT03062813Phase 4Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Feb 2017
- Primary completion
- Feb 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in hepatitis B virus-associated glomerulonephritis (HBV-GN), sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
hepatitis B virus-associated glomerulonephritis (HBV-GN)
Beyond the preview
Go deeper on NCT03062813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062813.